Abstract
The effects of aalproate on CNS concentrations of γ-aminobutyric acid (GABA), glutamate (GLU), glutamine (GLN), dopamine (DA), serotonin (5-HT), and metabolites were examined in tissue extracts of caudate nucleus of genetic substrains of Balb/c mice susceptible (EP) or resistant (ER) to audiogenic seizures. Generalized tonic-clonic seizures observed in EP mice were inhibited by valproate, administered 1 h prior to testing, in a dose-response fashion. Concentrations of GABA, GLU, and GLN, which were lower in EP mice than in ER mice, were significantly increased by valproate at doses of 180 and 360 mg/kg. Concentrations of homovanillic acid (HVA) and hydroxyindoleacetic acid (5-HIAA), metabolites of DA and 5-HT were substantially increased by valproate at these doses. Thein situ activity of tyrosine hydroxylase (TH) was not significantly influenced by valproate, whereas a valproate-induced increase in tryptophan hydroxylase (TPH) activity was observed in both striatum and in midbrain tegmentum. The data are consistent with the interpretation that anticonvulsive doses of valproate influences the intraneuronal metabolism of monoamines, GABA, and glutamate concurrently. Valproate’s influence on the metabolism of both major inhibitory (GABA) and excitatory (GLU) amino acids in striatum could contribute to its anticonvulsive effects in genetically seizure-prone mice, as well as to the accumulation of DA and 5-HT metabolites.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Al-Tajir G., Chandler C. J., Starr B. S., and Star M. S. (1990) Opposite effects of stimulation of D1 and D2 dopamine receptors on the expression of motor seizures in mouse and rat.Neuropharmacology 29, 657–661.
Anlezark G., Horton R. W., Meldrum S. S., and Sawaya M. C. B. (1976) Anticonvulsant action of ethanolamine-O-sulphate and di-n-propylacetate and the metabolism of γ-aminobutyric acid (GABA) in mice with audiogenic seizures.Biochem. Pharmacol. 25, 413–417.
Biggs C. S., Pearce B. R., Fowler L. J., and Whitton P. S. (1992) Regional effects of sodium valproate on extracellular concentrations of 5-hydroxytryptamine, dopamine, and their metabolites in the rat brain anin vivo microdialysis study.J. Neurochem. 59, 1702–1708.
Browning R. A. (1986) Neurobiology of seizure disposition in the genetically epilepsy-prone rat. Neuroanatomical localization of structures responsible for seizures in the GEPR: Lesion studies.Life Sci. 39, 857–867.
Browning R., Nelson D., Mogharreban N., Jobe P., and Laird H. (1985) Effect of midbrain and pontine tegmental lesions of audiogenic seizures in genetically epilepsy-prone rats.Epilepsia 26, 175–183.
Carlsson A., Davis J. N., Kehr W., Lindqvist M., and Atack C. V. (1972) Simultaneous measurement of tyrosine and tryptophan hydroxylase activities in brainin vivo using an inhibitor of the aromatic amino acid decarboxylase.Arch. Pharmacol. 275, 153–168.
Chapman A., Keane P. E., Meldrum B. S., Simiand J., and Vernieres J. C. (1982a) Mechanism of anticonvulsant action of valproate.Prog. Neurobiol. 19, 315–359.
Chapman A. G., Riley K., Evans M. C., and Meldrum B. S. (1982b) Acute effects of sodium valproate and γ-vinyl GABA on regional amino acid metabolism in the rat brain: Incorporation of 2-(14C)-glucose into amino acids.Neurochem. Res. 7, 1089–1105.
Chapman A. G., Meldrum B. S., Nanji N., and Watkins J. C. (1987) Anticonvulsant action and biochemical effects in DBA/2 mice of CPP (3-((+/−)-2-carboxypiperazin-4-yl)-propyl-1-phosphonate), a novelN-methyl-d-aspartate antagonist.Eur. J. Pharmacol. 139, 91–96.
Faingold C. L., Randall M. E., Naritoku D. K., and Boersma-Anderson C. A. (1993) Noncompetitive and competitive NMDA antagonists exert anticonvulsant effects by actions on different sites within the neuronal network for audiogenic seizures.Exp. Neurol. 119, 198–204.
Fohlmeister J., Adelman W., and Breman J. (1984) Excitable channel currents and gating times in the presence of anticonvulsants, ethosuximide and valproate.J. Pharmacol. Exp. Ther. 230, 75–81.
Gale K. and Browning R. A. (1988) Anatomical and neurochemical substrates of clonic and tonic seizures, inMechanims of Epileptogenesis (Dichter M. A., ed.), pp. 111–152. Phenum, New York.
Gamache P., Ryan E., Svendsen C., Murayama K., and Acworth I. N. (1993) Simultaneous measurement of monoamines, metabolites and amino acids in brain tissue and microdialysis perfusates.J. Chromatog. 614, 213–220.
Godin Y., Heiner L., Mark J., and Mandel P. (1969) Effects of di-n-propylacetate, an anticonvulsive compound, on GABA metabolism.J. Neurochem. 16, 869–873.
Grace A. A. and Bunney B. S. (1979) Paradoxical GABA excitation of nigral dopaminergic cells: indirect mediation through reticulata inhibitory neurons.Eur. J. Pharmacol. 59, 211–218.
Horton R. W., Anglezark G. M., Sawaya C. B., and Meldrum S. S. (1977) Monoamine and GABA metabolism and the anticonvulsant action of di-n-propylacetate and ethanolamine-O-sulphate.Eur. J. Pharmacol. 41, 387–397.
Iadarola M. J., Raines A., and Gale K. (1979) Differential effects of n-dipropylacetate and amino-oxyacetic acid on gamma-aminobutyric acid levels in discrete areas of rat brain.J. Neurochem. 33, 1119–1123.
Iadarola M. and Gale K. (1982) Substantia nigra: site of anticonvulsant activity mediated by gammabutyric acid.Science 218, 1237–1240.
Kesner R. (1966) Subcortical mechanisms of audiogenic seizures.Exp. Neurol. 15, 192–205.
Klockgether T., Turski L., Honore T., Zhang Z. M., Gash D. M., Kurlan R., and Greenamyre J. T. (1991) The AMPA receptor antagonist NBQX has antipark-insonian effects in monoamine-depleted rats and MPTP-treated monkeys.Ann. Neurol. 30, 717–723.
Kreigstein A. R. (1988) The pathogenesis of epilepsy: relevance to therapy.Curr. Opin. Neurol. Neurosurg. 1, 200–205.
Kukino K. and Deguchi T. (1977) Effects of sodium dipropylacetate and γ-aminobutyric acid and biogenic amines in rat brain.Chem. Pharm. Bull. 25, 2257–2262.
Lehmann J. Chapman A. G., Meldrum B. S., Hutchison A., Tsai C., and Wood P. L. (1988) CGS 19755 is a potent and competitive antagonist at NMDA-type receptors.Eur. J. Pharmacol. 154, 89–93.
Loscher W. (1981) Valproate induced changes in GABA metabolism at the subcellular level.Biochem. Pharmacol. 30, 1364–1366.
Loscher W. (1989) Valproate enhances GABA turnover in the substantia nigra.Brain Res. 501, 198–203.
Loscher W. (1993) Effects of the antiepileptic drug valproate on metabolism and function of inhibitory and excitatory amino acids in the brain.Neurochem. Res. 18, 485–502.
Macdonald R. L. and Kelly K. M. (1993) Antiepileptic drug mechanisms of action.Epilepsia 34, S1–8.
MacMillian V. (1979) The effects of the anticonvulsant valproic acid on cerebral indole amine metabolism.Can. J. Physiol. Pharmacol. 57, 843–847.
McLean M. and Macdonald R. (1986) Sodium valproate, but not ethosuximide, produces use- and voltage-dependent limitation of high frequency repetitive firing of action potentials of mouse central neurons in cell culture.J. Pharmacol. Exp. Ther. 237, 1001–1011.
Miller J. W. and Ferrendelli J. A. (1988) Some subcortical mechanisms involved in experimental generalized seizures, inMechanisms of Epileptogenesis (Dichter M. A., ed.), pp. 101–110, Plenum, New York.
Mitsikostas D., Sfikakis A., Papadopoulou-Daifoti Z., and Varonos D. (1993) The effects of valproate in brain monomanies of juvenile rats after stress.Prog. Neurospsychopharmacol.Biol. Psychiatry 17, 295–310.
Nichols A. C. and Yielding K. L. (1993) Anticonvulsant activity of antagonists for the NMDA-associated glycine binding site.Mol. Chem. Neuropathol. 19, 269–282.
Preisendorfer U., Zeise M. L., and Klee M. R. (1987) Valproate enhances inhibitory postsynaptic potentials in hippocampal neurons in vitro.Brain Res. 435, 213–219.
Sawaya M. C. B., Horton R. W., and Meldrum B. S. (1975) Effects of anticonvulsant drugs on the cerebral enzymes metabolising GABA.Epilepsia 16, 649–655.
Semenova T. P. and Ticku M. K. (1992) Effects of 5-HT receptor antagonists on seizure-susceptibility and locomotor activity in DBA/2 mice.Brain Res. 588, 229–236.
Simler S., Ciesielski L., Maitre M., Randrianarisoa H., and Mandel P. (1973) Effect of sodiumn-dipropylacetate on audiogenic seizures and brain γ-aminobutyric acid level.Biochem. Pharmacol. 22, 1701–1708.
Thomsen C., Klitgaard H., Sheardown M., Jackson H. C., Eskesen K., Jacobsen P. Treppendahl S., and Suzdak P. D. (1994) (S)-4-carboxy-3-hydroxyphenyl-glycine, an agtagonist of metabotrophic glutamate receptor (mGluR) 1a and an agonist of mGluR2, protects against audiogenic seizures in DBA/2 mice.J. Neurochem. 62L, 2492–2495.
Turski L., Meldrum B., Cavalheiro E., Calderazzo-Filho L., Bortolotto Z., Ikonomidou-Turski C., and Turski W. (1987) Paradoxical anticonvulsant activity of the excitatory amino acid N-methl-d-aspartate in the rat caudate-putamen.Proc. Natl. Acad. Sci. USA 84, 1689–1693.
Vriend J., Alexiuk N. A. M., Green-Johnson J., and Ryan R. (1993) Determination of amino acids and monoamine neurotransmitters in caudate nucleus of seizure-resistant and seizure-prone Balb/c mice.J. Neurochem. 60, 1300–1307.
Whitton P. S., Oreskovic D., Markovic Z., Skarpa D., and Bulat M. (1983) Effect of the antiepiletic DI-n-propylacetamide on 5-hydroxytryptamine turnover in the brain and 5-hydroxyindoleacetic acid level in the cerebrospinal fluid.Eur. J. Pharmacol. 91, 57–62.
Whitton P. S., Oreskovic D., Jernej B., and Bulat M. (1985) Effect of valproic acid on 5-hydroxytryptamine turnover in mouse brain.J. Pharm. Pharmacol. 37, 199–200.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Vriend, J.P., Alexiuk, N.A.M. Effects of valproate on amino acid and monoamine concentrations in striatum of audiogenic seizure-prone balb/c mice. Molecular and Chemical Neuropathology 27, 307–324 (1996). https://doi.org/10.1007/BF02815111
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02815111